Axonics, Inc.
AXNXDelisted Nov 15, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001603756
Axonics, Inc. was delisted on Nov 15, 2024; its insiders filed their last Form 4 on Nov 15, 2024; 233 institutions reported holding it in 13F filings for Q3 2024, worth $3.54B in total; Soros Fund Management was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Axonics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Axonics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Carrel Michael H | Director | 0 | Nov 15, 2024 | 0 |
| Cohen Raymond W | Chief Executive Officer | 0 | Nov 15, 2024 | 0 |
| Ford Alfred J Jr | Chief Commercial Officer | 0 | Nov 15, 2024 | 0 |
| Kiernan Jane E | Director | 0 | Nov 15, 2024 | 0 |
| McNamara Robert | Director | 0 | Nov 15, 2024 | 0 |
| Demski David M | Director | 0 | Nov 15, 2024 | 0 |
| snyderman nancy lynn MD | Director | 0 | Nov 15, 2024 | 0 |
| Noblett Karen | Chief Medical Officer | 0 | Nov 15, 2024 | 0 |
| Sama Rinda | Chief Operating Officer | 0Indirect | Nov 15, 2024 | 0 |
| Woock John | EVP, Chief Mktg/Strtgy Officer | 0 | Nov 15, 2024 | 0 |
| Lopez Esteban | Director | 0 | Nov 15, 2024 | 0 |
| Keese Kari Leigh | Chief Financial Officer | 0 | Nov 15, 2024 | 0 |
| Dearen Danny L. | President & CFO | 23,777 | Oct 3, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Cohen Raymond WChief Executive Officer | SSale | −35.2K | $67.74 | −$2.38M | −15.7%188.8K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Keese Kari LeighChief Financial Officer | SSale | −3.49K | $67.74 | −$236.3K | −7.5%43.3K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Ford Alfred J JrChief Commercial Officer | SSale | −16.6K | $67.74 | −$1.13M | −27.7%43.5K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Woock JohnEVP, Chief Mktg/Strtgy Officer | SSale | −15.9K | $67.74 | −$1.08M | −17.0%77.4K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Noblett KarenChief Medical Officer | SSale | −11.3K | $67.74 | −$764.6K | −24.7%34.4K after | |
| Oct 3, 2024 (view filing) | Oct 2 | 1 day | Keese Kari LeighChief Financial Officer | SSale | −2.96K | $69.41 | −$205.5K | −6.8%40.4K after | 2 lots |